Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.

Cavo M, Pantani L, Petrucci MT, Patriarca F, Zamagni E, Donnarumma D, Crippa C, Boccadoro M, Perrone G, Falcone A, Nozzoli C, Zambello R, Masini L, Furlan A, Brioli A, Derudas D, Ballanti S, Dessanti ML, De Stefano V, Carella AM, Marcatti M, Nozza A, Ferrara F, Callea V, Califano C, Pezzi A, Baraldi A, Grasso M, Musto P, Palumbo A; GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network.

Blood. 2012 Jul 5;120(1):9-19. doi: 10.1182/blood-2012-02-408898. Epub 2012 Apr 12.

2.

Cutaneous T-cell/histiocyte-rich B-cell lymphoma: a case report and review of the literature.

Vezzoli P, Fiorani R, Girgenti V, Fanoni D, Tavecchio S, Balice Y, Mozzana R, Crosti C, Berti E.

Dermatology. 2011;222(3):225-30. doi: 10.1159/000327376. Epub 2011 Apr 30. Review.

PMID:
21540569
3.

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.

Cavo M, Tacchetti P, Patriarca F, Petrucci MT, Pantani L, Galli M, Di Raimondo F, Crippa C, Zamagni E, Palumbo A, Offidani M, Corradini P, Narni F, Spadano A, Pescosta N, Deliliers GL, Ledda A, Cellini C, Caravita T, Tosi P, Baccarani M; GIMEMA Italian Myeloma Network.

Lancet. 2010 Dec 18;376(9758):2075-85. doi: 10.1016/S0140-6736(10)61424-9. Epub 2010 Dec 9. Erratum in: Lancet. 2011 Nov 26;378(9806):1846.

PMID:
21146205
4.

Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial.

Di Bartolomeo M, Buzzoni R, Mariani L, Ferrario E, Katia D, Gevorgyan A, Zilembo N, Bordonaro R, Bochicchio AM, Massidda B, Ardizzoia A, Marini G, Aitini E, Schieppati G, Comella G, Pinotti G, Palazzo S, Cicero G, Bajetta E; Italian Trial in Medical Oncology (ITMO) Group, Villa E, Fagnani D, Reguzzoni G, Agostana B, Oliani C, Kildani B, Duro M, Botta M, Mozzana R, Mantovani G.

Oncology. 2006;71(5-6):341-6. Epub 2007 Sep 14. Erratum in: Oncology. 2007;73(5-6):406. Ardizzoni, Antonio [corrected to Ardizzoia, Antonio].

PMID:
17855795
5.

Long term results of a randomized study performed by Intergruppo Italiano Linfomi comparing Mini-CEOP vs P-VEBEC in elderly patients with diffuse large B-cell lymphoma.

Merli F, Bertini M, Luminari S, Mozzana R, Botto B, Liberati AM, Baldini L, Cabras G, Di Vito F, Orsucci L, Naglieri E, Polimeno G, Marcheselli L, Pennese E, Vitolo U, Federico M, Gallo E.

Leuk Lymphoma. 2007 Feb;48(2):367-73.

PMID:
17325898
6.

Quality of life assessment in elderly patients with aggressive non-Hodgkin's Lymphoma treated with anthracycline-containing regimens. Report of a prospective study by the Intergruppo Italiano Linfomi.

Merli F, Bertini M, Luminari S, Mozzana R, Bertè R, Trottini M, Stelitano C, Botto B, Pizzuti M, Quintana G, De Paoli A, Federico M; Intergruppo Italiano Linfomi.

Haematologica. 2004 Aug;89(8):973-8.

7.

Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group.

Zucca E, Conconi A, Mughal TI, Sarris AH, Seymour JF, Vitolo U, Klasa R, Ozsahin M, Mead GM, Gianni MA, Cortelazzo S, Ferreri AJ, Ambrosetti A, Martelli M, Thiéblemont C, Moreno HG, Pinotti G, Martinelli G, Mozzana R, Grisanti S, Provencio M, Balzarotti M, Laveder F, Oltean G, Callea V, Roy P, Cavalli F, Gospodarowicz MK; International Extranodal Lymphoma Study Group.

J Clin Oncol. 2003 Jan 1;21(1):20-7.

PMID:
12506165
8.

[Symmetric multiple lipomatosis. A case report with an unusual onset].

Ciambelli F, Limbiati S, Mattaini R, Mozzana R.

Minerva Med. 2000 May-Jun;91(5-6):123-6. Italian.

PMID:
11084847
9.

EBVD and alternating MOPP/EBVD with or without localized field radiotherapy in advanced or unfavorably presenting Hodgkin's disease.

Pogliani EM, Deliliers GL, Baldini L, Tosi A, Butti C, Chiorboli O, Confalonieri C, Fava S, Giorgetti MC, Maioli M, Maiolo AT, Marinoni P, Montalbetti L, Mozzana R, Pavia G, Pinotti G, Rossini F, Vanoli P, Venco A, Cassi E.

Haematologica. 1996 Jan-Feb;81(1):8-14.

10.

Single-institution results of autologous bone marrow transplantation in acute myeloid leukemia.

Lambertenghi Deliliers G, Annaloro C, Della Volpe A, Oriani A, Mozzana R, Pozzoli E, Tagliaferri E, Soligo D.

Haematologica. 1995 Mar-Apr;80(2):136-41.

11.

Idarubicin in the therapy of acute myeloid leukemia: final analysis in 57 previously untreated patients.

Lambertenghi Deliliers G, Annaloro C, Oriani A, Pozzoli E, Cortelezzi A, Cortellaro M, Mozzana R, Della Volpe A, Soligo D, Cofrancesco E, et al.

Semin Oncol. 1993 Dec;20(6 Suppl 8):27-33.

PMID:
8290969
12.

Long-term results of autologous bone marrow transplantation in adult acute lymphoblastic leukemia.

Lambertenghi Deliliers G, Mozzana R, Annaloro C, Butti C, Della Volpe A, Oriani A, Pozzoli E, Soligo D, Polli EE.

Leuk Lymphoma. 1993 Nov;11(5-6):419-25.

PMID:
8124215
13.
14.

Autologous bone marrow transplantation for acute myeloid and lymphoid leukemia.

Rizzoli V, Carlo-Stella C, Almici C, Garau D, Carella AM, Coser P, Angrilli F, Bernabei PA, Mozzana R, Alessandrino E, et al.

Leukemia. 1992 Nov;6 Suppl 4:103-5. No abstract available.

PMID:
1434811
15.

Use of high-dose cytarabine in autologous bone marrow transplantation in acute myeloid leukemia.

Mozzana R, Della Volpe A, Butti C, Fossati V, Selva S, Deliliers GL.

Leuk Lymphoma. 1992;7 Suppl:45-9.

PMID:
1493459
16.

Abnormal Neutrophil Chemotaxis after Successful Bone Marrow Transplantation.

Capsoni F, Minonzio F, Ongari AM, Soligo D, Luksch R, Mozzana R, Volpe AD, Deliliers GL.

Leuk Lymphoma. 1991;4(5-6):335-41. doi: 10.3109/10428199109068083.

PMID:
27467665
17.

Purging procedures for acute leukaemias in autologous BMT.

Rizzoli V, Mangoni L, Carella AM, Coleselli P, Angrilli F, Alessandrino EP, Miniero A, Novarino A, Falda M, Mozzana R, et al.

Bone Marrow Transplant. 1989 Dec;4 Suppl 4:77-80. No abstract available.

PMID:
2697443
18.

Idarubicin plus cytarabine as first-line treatment of acute nonlymphoblastic leukemia.

Lambertenghi-Deliliers G, Annaloro C, Cortelezzi A, Cortellaro M, Della Volpe A, Maiolo AT, Mozzana R, Pogliani E, Pozzoli E, Polli EE.

Semin Oncol. 1989 Feb;16(1 Suppl 2):16-20. No abstract available.

PMID:
2928806
19.

Biological characterization of refractory anemia with excess of blasts.

Maiolo AT, Foa P, Pagetti D, Baldini L, Mozzana R, Ortolani S, Colantoni A, Lombardi L, Lavezzi AM, Polli EE.

Haematologica. 1987 Nov-Dec;72(6 Suppl):126-9. Review. No abstract available.

PMID:
3127288
20.

Autologous bone marrow transplantation in acute leukemia.

Mangoni L, Degliantoni G, Porcellini A, Carella AM, Alessandrino EP, Aglietta M, Resegotti L, Torlontano G, Coleselli P, Mozzana R, et al.

Acta Haematol. 1987;78 Suppl 1:190-3.

PMID:
3124446
Items per page

Supplemental Content

Loading ...
Write to the Help Desk